Cancer Home > Pazopanib

Pazopanib is a drug prescribed to treat advanced renal cell carcinoma (kidney cancer) and soft tissue carcinoma. By blocking an enzyme in the body, this medication can slow down the growth of cancer cells. It comes in tablet form and is taken once daily. Loss of appetite, nausea, and diarrhea are some of the most commonly reported reactions to this drug.

What Is Pazopanib?

Pazopanib (Votrient®) is a prescription medication approved for the treatment of advanced renal cell carcinoma (kidney cancer) and advanced soft tissue sarcoma (cancer of the body's soft tissues). It belongs to a group of medicines called tyrosine kinase inhibitors.
(Click What Is Pazopanib Used For? for more information on this topic, including possible off-label uses.)

Are There Side Effects?

Just like any medicine, pazopanib may cause side effects. However, not everyone who takes the drug will experience problems. In fact, most people tolerate it quite well.
If reactions do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
Common side effects of pazopanib include but are not limited to:
(Click Pazopanib Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.